George Hill Analyst PerformanceManaging Director, Equity Research Analyst at Deutsche Bank AktiengesellschaftGeorge Hill is a stock analyst at Deutsche Bank Aktiengesellschaft focused in the medical sector, covering 25 publicly traded companies. Over the past year, George Hill has issued 6 stock ratings, including buy, hold, and sell recommendations. While full access to George Hill's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights George Hill's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings158 Last 11 YearsBuy Recommendations52.32% 79 Buy RatingsCompanies Covered25 Unique Companies Ratings Distribution151RatingsDistribution of strong buy, buy, hold, and sell ratings by George Hill.RatingPercentageCount Strong Buy0.0%0 ratings Buy52.3%79 ratings Hold39.1%59 ratings Sell8.6%13 ratingsOut of 151 total stock ratings issued by George Hill at Deutsche Bank Aktiengesellschaft, the majority (52.3%) have been Buy recommendations, followed by 39.1% Hold and 8.6% Sell.Best & Worst CallsBest Call000.0%EHTHApr 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ONEMJun 2021Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ52.0% of companies on NASDAQ13 companiesNYSE48.0% of companies on NYSE12 companiesGeorge Hill, an analyst at Deutsche Bank Aktiengesellschaft, currently covers 25 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical18 companies72.0%Miscellaneous3 companies12.0%Retail/Wholesale2 companies8.0%Business Services1 company4.0%Finance1 company4.0%George Hill of Deutsche Bank Aktiengesellschaft specializes in stock coverage within the Medical sector, with additional focus on and Retail/Wholesale companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES5 companies20.0%MED - HMO3 companies12.0%COMPUTER INTEGRATED SYSTEMS DESIGN3 companies12.0%MED/DENTAL - SUPP2 companies8.0%DRUG STORES & PROPRIETARY STORES2 companies8.0%Miscellaneous2 companies8.0%RETAIL - DRUG STR1 company4.0%OFFICES & CLINICS OF MEDICAL DOCTORS1 company4.0%INS - BROKERS1 company4.0%PHARMACEUTICAL PREPARATIONS1 company4.0%MED INSTRUMENTS1 company4.0%PREPACKAGED SOFTWARE1 company4.0%HOLDING & OTHER INVESTMENT OFFICES1 company4.0%CUSTOM COMPUTER PROGRAMMING SERVICES1 company4.0% About George HillGeorge Hill joined Deutsche Bank as a Managing Director and equity research analyst covering the Healthcare Technology & Service sector in April 2019. He's been covering the healthcare technology and pharmaceutical services space for over 20 years. Mr. Hill frequently appears in the media, as a regular speaker at industry events, and lectured at the Wharton School on healthcare technology topics. He was Managing Director and senior equity research analyst at RBC Capital Markets, covering the drug supply chain and healthcare technology industries. Prior to RBC, he held similar positions at Deutsche Bank, Citigroup and SVB Leerink. He spent time as the senior calling officer for Leerink's healthcare services investment banking group. Mr. Hill started his career in investment research as an investment associate at Citigroup Asset Management. Before that, he was a journalist covering the pharmaceutical marketing and services space. Mr. Hill holds a bachelor's degree from Rutgers University.Follow on LinkedIn George Hill's Ratings History at Deutsche Bank Aktiengesellschaft Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsMCKMcKesson9/24/2025Boost Price Target$739.48$856.00Buy$0.0000.00% ROIGDRXGoodRx8/11/2025Reiterated Rating$3.47$6.00Hold$0.0000.00% ROICICigna Group8/5/2025Set Price Target$271.17$415.00Buy$0.0000.00% ROIHQYHealthEquity6/5/2025Boost Price Target$114.87$115.00Buy$0.0000.00% ROIUNHUnitedHealth Group5/14/2025Lower Price Target$311.69$362.00Buy$0.0000.00% ROIWBAWalgreens Boots Alliance2/28/2025Downgrade$11.23$9.00Sell$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
